ARGX Q4 2021 Earnings — argenx SE Revenue & Financial Results | Market Cap Arena

ARGXargenx SE

$46B

Q4 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$26M+15.0% YoY

Gross Profit

-$243M-934.6% margin

Operating Income

-$390M-1497.7% margin

Net Income

-$414M-1590.7% margin

EPS (Diluted)

$-8.04

Cash Flow

Operating Cash Flow

-$335M

Free Cash Flow

-$336M

Stock-Based Comp.

$87M

Balance Sheet

Total Assets

$2.9B

Total Liabilities

$316M

Stockholders' Equity

$2.5B

Cash & Equivalents

$1.3B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$26M	$23M	+15.0%
Gross Profit	-$243M	-$126M	-93.1%
Operating Income	-$390M	-$209M	-86.3%
Net Income	-$414M	-$313M	-32.5%